Enrichment analysis of genes dysregulated following Motexafin gadolinium (4 h) treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00013969
TitleEnrichment analysis of genes dysregulated following Motexafin gadolinium (4 h) treatment
DescriptionAn enrichment analysis was performed on the top most dyresgulated genes determined by applying the principal angle method to compare gene expression between Motexafin gadolinium (4 h) treated cells and untreated control cells in the A549 cell type.
Analysis URLhttp://amp.pharm.mssm.edu/PAEA?id=3088082
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis CuratorAliDot
CREEDS IDdrug:3125
Cell TypeA549
Drug NameMotexafin gadolinium (4 h)
DrugBank IDDB05428
Organismhuman
SMILES ID[O-]C(=O)C.[O-]C(=O)C.OCCCC1=C(C)/C/2=C/N=c/3\cc(OCCOCCOCCOC)c(c\c3=N/C=C/3\N=C(/C=c/4\[n-]/c(=C\C1=N2)/c(CC)c4CC)C(=C3C)CCCO)OCCOCCOCCOC.[Gd+3]
Characteristic Direction parameters
Control SamplesGSM39804, GSM39805, GSM39806
Perturbed SamplesGSM39801, GSM39802, GSM39803
Tools used in the analysis
Dataset Accession
PAEA
Published November 2015
Enrichment analysis tool implementing the principal angle method
3879
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE2189
Gene Expression Omnibus
Lung cancer cell line response to motexafin gadolinium: time course
7
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.